Advertisement

Posterior enucleation of the pancreatic head: an alternative route of access for parenchyma-sparing pancreatic resection

  • Michael S. Pärli
  • Philip C. Müller
  • Sascha A. Müller
  • Claudio M. Ruzza
  • Kaspar Z’graggenEmail author
How-I-Do-It articles
  • 17 Downloads

Abstract

Background

Enucleation has become an alternative treatment in benign or low-malignant cystic tumors, including intraductal papillary mucinous neoplasms (IPMN). For enucleation to be a safe alternative to the standard procedures, there must be good access to the resection area. In this report, we present such a route for dorsally situated IPMNs.

Methods

The head of the pancreas was exposed by an extended Kocher maneuver to the left lateral edge of the aorta. Stay sutures were placed along the second part of the duodenum to allow maximal rotation of the pancreatic head to the left, which exposed the posterior aspect of the pancreatic head. The cystic lesion was then enucleated followed by a protective pancreaticojejunostomy on the resection cavity.

Results

Two consecutive patients with IPMNs of the dorsal pancreatic head successfully underwent dorsal enucleation. The postoperative course was uneventful in the first patient, while the course of the second patient was complicated by a clinically relevant pancreatic fistula, delayed gastric emptying, and hospital discharge on day 35.

Conclusion

This study shows the feasibility of a dorsal approach to the pancreatic head for enucleation as well as reconstruction by means of posterior Roux-en-Y pancreaticojejunostomy. In very selected cases in specialized centers, cystic lesions in the posterior aspect of the pancreatic head will become amenable to enucleation with preservation of pancreatic functionality. However, more research is needed to clarify postoperative outcomes of this approach.

Keywords

Pancreatic resection Enucleation Cystic pancreatic lesion IPMN Surgical technique 

Notes

Authors’ contributions

Study conception and design: Müller SA, Müller PC, and Z’graggen K. Acquisition of data: Z’graggen K, Müller SA, and Pärli MS, Razza C. Analysis and interpretation of data: Pärli MS, Müller PC, and Ruzza C. Drafting of manuscript: Pärli MS, Müller SA, and Müller PC. Critical revision: Ruzza C and Z’graggen K.

Funding information

The study was funded by institutional means.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Supplementary material

423_2019_1835_MOESM1_ESM.mp4 (316.7 mb)
Video 1 (MP4 324056 kb)

References

  1. 1.
    Pinho DF, Rofsky NM, Pedrosa I (2014) Incidental pancreatic cysts: role of magnetic resonance imaging. Top Magn Reson Imaging TMRI 23:117–128.  https://doi.org/10.1097/RMR.0000000000000018 CrossRefPubMedGoogle Scholar
  2. 2.
    Grutzmann R, Niedergethmann M, Pilarsky C, Kloppel G, Saeger HD (2010) Intraductal papillary mucinous tumors of the pancreas: biology, diagnosis, and treatment. The Oncologist 15:1294–1309.  https://doi.org/10.1634/theoncologist.2010-0151 CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Tanaka M, Fernández-del Castillo C, Adsay V, Chari S, Falconi M, Jang J-Y, Kimura W, Levy P, Pitman MB, Schmidt CM, Shimizu M, Wolfgang CL, Yamaguchi K, Yamao K, International Association of Pancreatology (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatol Off J Int Assoc Pancreatol IAP Al 12:183–197.  https://doi.org/10.1016/j.pan.2012.04.004 CrossRefGoogle Scholar
  4. 4.
    Hackert T, Fritz S, Büchler MW (2015) Main- and branch-duct intraductal papillary mucinous neoplasms: extent of surgical resection. Viszeralmedizin 31:38–42.  https://doi.org/10.1159/000375111 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Miller JR, Meyer JE, Waters JA, Al-Haddad M, DeWitt J, Sherman S, Lillemoe KD, Schmidt CM (2011) Outcome of the pancreatic remnant following segmental pancreatectomy for non-invasive intraductal papillary mucinous neoplasm. HPB 13:759–766.  https://doi.org/10.1111/j.1477-2574.2011.00354.x CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Käppeli RM, Müller SA, Hummel B, Kruse C, Müller P, Fornaro J, Wilhelm A, Zadnikar M, Schmied BM, Tarantino I (2013) IPMN: surgical treatment. Langenbecks Arch Surg 398:1029–1037.  https://doi.org/10.1007/s00423-013-1106-1 CrossRefPubMedGoogle Scholar
  7. 7.
    Tanaka M, Fernández-del Castillo C, Kamisawa T, Jang JY, Levy P, Ohtsuka T, Salvia R, Shimizu Y, Tada M, Wolfgang CL (2017) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology.  https://doi.org/10.1016/j.pan.2017.07.007 CrossRefGoogle Scholar
  8. 8.
    Hüttner FJ, Koessler-Ebs J, Hackert T, Ulrich A, Büchler MW, Diener MK (2015) Meta-analysis of surgical outcome after enucleation versus standard resection for pancreatic neoplasms. Br J Surg 102:1026–1036.  https://doi.org/10.1002/bjs.9819 CrossRefPubMedGoogle Scholar
  9. 9.
    Song KB, Kim SC, Hwang DW, Lee JH, Lee DJ, Lee JW, Jun ES, Sin SH, Kim HE, Park K-M, Lee Y-J (2015) Enucleation for benign or low-grade malignant lesions of the pancreas: single-center experience with 65 consecutive patients. Surgery 158:1203–1210.  https://doi.org/10.1016/j.surg.2014.10.008 CrossRefPubMedGoogle Scholar
  10. 10.
    Faitot F, Gaujoux S, Barbier L, Novaes M, Dokmak S, Aussilhou B, Couvelard A, Rebours V, Ruszniewski P, Belghiti J, Sauvanet A (2015) Reappraisal of pancreatic enucleations: a single-center experience of 126 procedures. Surgery 158:201–210.  https://doi.org/10.1016/j.surg.2015.03.023 CrossRefPubMedGoogle Scholar
  11. 11.
    Hwang HK, Park JS, Kim JK, Park C-M, Cho SI, Yoon DS (2012) Comparison of efficacy of enucleation and pancreaticoduodenectomy for small (<3 cm) branch duct type intraductal papillary mucinous neoplasm located at the head of pancreas and the uncinate process. Yonsei Med J 53:106–110.  https://doi.org/10.3349/ymj.2012.53.1.106 CrossRefPubMedGoogle Scholar
  12. 12.
    Sauvanet A, Gaujoux S, Blanc B, Couvelard A, Dokmak S, Vullierme M-P, Ruszniewski P, Belghiti J, Lévy P (2014) Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 260:364–371.  https://doi.org/10.1097/SLA.0000000000000601 CrossRefPubMedGoogle Scholar
  13. 13.
    Heeger K, Falconi M, Partelli S, Waldmann J, Crippa S, Fendrich V, Bartsch DK (2014) Increased rate of clinically relevant pancreatic fistula after deep enucleation of small pancreatic tumors. Langenbecks Arch Surg 399:315–321.  https://doi.org/10.1007/s00423-014-1171-0 CrossRefPubMedGoogle Scholar
  14. 14.
    Brient C, Regenet N, Sulpice L, Brunaud L, Mucci-Hennekine S, Carrère N, Milin J, Ayav A, Pradere B, Hamy A, Bresler L, Meunier B, Mirallié E (2012) Risk factors for postoperative pancreatic fistulization subsequent to enucleation. J Gastrointest Surg 16:1883–1887.  https://doi.org/10.1007/s11605-012-1971-x CrossRefPubMedGoogle Scholar
  15. 15.
    Xiao Z, Luo G, Liu Z, Jin K, Xu J, Liu C, Liu L, Ni Q, Long J, Yu X (2016) Roux-en-Y pancreaticojejunostomy reconstruction after deep enucleation of benign or borderline pancreatic lesions: a single-institution experience. HPB 18:145–152.  https://doi.org/10.1016/j.hpb.2015.08.007 CrossRefPubMedGoogle Scholar
  16. 16.
    Lassen K, Coolsen MME, Slim K, Carli F, de Aguilar-Nascimento JE, Schäfer M, Parks RW, Fearon KCH, Lobo DN, Demartines N, Braga M, Ljungqvist O, Dejong CHC, ERAS® Society, European Society for Clinical Nutrition and Metabolism, International Association for Surgical Metabolism and Nutrition (2012) Guidelines for perioperative care for pancreaticoduodenectomy: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Clin Nutr Edinb Scotl 31:817–830.  https://doi.org/10.1016/j.clnu.2012.08.011 CrossRefGoogle Scholar
  17. 17.
    Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, Neoptolemos JP, Padbury RT, Sarr MG, Traverso LW, Yeo CJ, Büchler MW (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 142:761–768.  https://doi.org/10.1016/j.surg.2007.05.005 CrossRefPubMedGoogle Scholar
  18. 18.
    Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M, International Study Group on Pancreatic Surgery (ISGPS) (2017) The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 years after. Surgery 161:584–591.  https://doi.org/10.1016/j.surg.2016.11.014 CrossRefPubMedGoogle Scholar
  19. 19.
    Beger HG, Nakao A, Mayer B, Poch B (2015) Duodenum-preserving total and partial pancreatic head resection for benign tumors – systematic review and meta-analysis. Pancreatology 15:167–178.  https://doi.org/10.1016/j.pan.2015.01.009 CrossRefPubMedGoogle Scholar
  20. 20.
    Soejima Y, Toshima T, Motomura T, Yokota T, Joko K, Oshiro Y, Takahashi I, Nishizaki T, Maehara Y (2017) Technical feasibility and oncological legitimacy of enucleation of intraductal papillary mucinous neoplasm located at the pancreatic head or uncinate process. Anticancer Res 37:321–326.  https://doi.org/10.21873/anticanres.11324 CrossRefPubMedGoogle Scholar
  21. 21.
    Kaiser J, Fritz S, Klauss M, Bergmann F, Hinz U, Strobel O, Schneider L, Büchler MW, Hackert T (2017) Enucleation: a treatment alternative for branch duct intraductal papillary mucinous neoplasms. Surgery 161:602–610.  https://doi.org/10.1016/j.surg.2016.09.026 CrossRefPubMedGoogle Scholar
  22. 22.
    Sahora K, Castillo CF, Dong F, Marchegiani G, Thayer SP, Ferrone CR, Sahani DV, Brugge WR, Warshaw AL, Lillemoe KD, Mino-Kenudson M (2014) Not all mixed-type intraductal papillary mucinous neoplasms behave like main-duct lesions: implications of minimal involvement of the main pancreatic duct. Surgery 156:611–621.  https://doi.org/10.1016/j.surg.2014.04.023 CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    European Study Group on Cystic Tumours of the Pancreas (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67:789–804.  https://doi.org/10.1136/gutjnl-2018-316027 CrossRefGoogle Scholar
  24. 24.
    Chua TC, Yang TX, Gill AJ, Samra JS (2016) Systematic review and meta-analysis of enucleation versus standardized resection for small pancreatic lesions. Ann Surg Oncol 23:592–599.  https://doi.org/10.1245/s10434-015-4826-3 CrossRefPubMedGoogle Scholar
  25. 25.
    Strobel O, Cherrez A, Hinz U, Mayer P, Kaiser J, Fritz S, Schneider L, Klauss M, Büchler MW, Hackert T (2015) Risk of pancreatic fistula after enucleation of pancreatic tumours: Pancreatic fistula after enucleation of pancreatic tumours. Br J Surg 102:1258–1266.  https://doi.org/10.1002/bjs.9843 CrossRefPubMedGoogle Scholar
  26. 26.
    Ohtsuka T, Mori Y, Fujimoto T, Miyasaka Y, Nakata K, Ohuchida K, Nagai E, Oda Y, Shimizu S, Nakamura M (2018) Feasibility of prophylactic pancreatojejunostomy in possible high-risk patients for prevention of pancreatic fistula during enucleation or limited pancreatic resection. Am Surg 84:149–153PubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of SurgeryKlinik Beau-SiteBernSwitzerland
  2. 2.Department of Visceral and Transplant SurgeryUniversity Hospital ZurichZurichSwitzerland

Personalised recommendations